# Yoav Chelouche

> Yoav Chelouche is a Series A investor at Aviv Venture Capital backing Sports and Medical. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Aviv Venture Capital](https://shizune.co/investors/profile/aviv-venture-capital)
- Total investments: 2
- Last investment: Nov 2014
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://il.linkedin.com/in/yoav-chelouche-43247b16

Yoav Chelouche is a Series A investor at Aviv Venture Capital focused on Sports and Medical. Yoav Chelouche has served on our board of directors since 2006. Chelouche has also served as one of our outside directors under the Israeli Companies Law since 2006. Chelouche has been Managing Partner of Aviv Venture Capital since August 2000. Prior to joining Aviv Venture Capital, Chelouche served as President and Chief Executive Officer ofScitex Corp., a world leader in digital imaging and printing systems, from December 1994 until July 2000. From August 1979 until December 1994, Chelouche held various managerial positions with Scitex, including VP Strategy and Business Development, VP Marketing and VP Finance for Europe. Chelouche is the Chairman of the Board of Rosetta Genomics Ltd., and a member of the board of directors of a number of private companies. He is also Chairman of Taasiyeda, an Israeli nonprofit organization that promotes the development of leadership and technology skills in children. Chelouche earned a B.A. in Economics and Statistics from Tel Aviv University, and a M.B.A. from INSEAD University in Fontainebleau, France.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Sports | 1 | 50% |
| Medical | 1 | 50% |
| Wellness | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Funding Round | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AposHealth | We at AposHealth® are passionate about revolutionizing the treatment of musculoskeletal conditions by simply addressing peoples’ gait to help alleviate pain and help them move better and live better. Our flagship solution, Apos®, is FDA-cleared to temporarily reduce knee pain caused by osteoarthritis. It can also be used as a general wellnessdevice to help patients live well with chronic lower back and hip pain. With a 96 percent satisfaction rate, over 110,000 patients treated, and dozens of peer-reviewed publications supporting the science behind Apos® as well as its clinical effect, this system—consisting of gait analysis, personalized foot-worn device, and a customized treatment plan—has helped patients with chronic knee, lower back, and hip pain worldwide move, live, and thrive. | $15M |  | Nov 25, 2014 |  |
| AposHealth | We at AposHealth® are passionate about revolutionizing the treatment of musculoskeletal conditions by simply addressing peoples’ gait to help alleviate pain and help them move better and live better. Our flagship solution, Apos®, is FDA-cleared to temporarily reduce knee pain caused by osteoarthritis. It can also be used as a general wellnessdevice to help patients live well with chronic lower back and hip pain. With a 96 percent satisfaction rate, over 110,000 patients treated, and dozens of peer-reviewed publications supporting the science behind Apos® as well as its clinical effect, this system—consisting of gait analysis, personalized foot-worn device, and a customized treatment plan—has helped patients with chronic knee, lower back, and hip pain worldwide move, live, and thrive. | $11M | Series A | Dec 01, 2011 |  |

2 of 2 investments shown.

## About Aviv Venture Capital

VC Fund · Petah Tiqva, Israel

Aviv Venture Capital is a private equity and venture capital firm that specializes in mid stage, bridge, and PIPE investments. The company invests in businesses which are at a phase of transforming from a research and development project to a full scale company. The firm seeks to invest in technology and consumer technologies companies based inIsrael. Aviv Venture Capital was founded by Amir Guttman in 2001 and is headquartered in Petach Tikva, Israel.

5 contacts available at Aviv Venture Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Yoav Chelouche | Managing Partner | https://shizune.co/investors/profile/yoav-chelouche |
| Amir Guttman | Founder & Managing Partner | https://shizune.co/investors/profile/amir-guttman |
| Dov Tadmor | Chairman of the Investment Committee | https://shizune.co/investors/profile/dov-tadmor |
| Gideon Y. Ben-Zvi | Venture Partner | https://shizune.co/investors/profile/gideon-y-ben-zvi |
| Sophie Caspi | CFO | https://shizune.co/investors/profile/sophie-caspi |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Yoav Chelouche invest in?

Yoav Chelouche invests primarily in Sports, Medical and Wellness startups, most often at Series A and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Yoav Chelouche last invest?

The most recent investment recorded for Yoav Chelouche closed in Nov 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co